Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-13

Clinical Trial Update: Lycopene in Treating Patients With Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating lycopene in patients with metastatic prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lycopene (lycopene)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED